Contra Fusion Pharmace
13F holders, Q1 2025 (March 31)1holders
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Contra Fusion Pharmace in their 13F filings, unchanged from Q3 2024. 1 opened new positions and 0 sold out. The largest holder was Skaana Management L.P. ($0).
- Company
- Contra Fusion Pharmace
- CUSIP
- 361CVR012
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q1 2025: 50,000 shares bought, net +50,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Skaana Management L.P. | 0.00% | New | 50,000 | $0 |
"% of holder's portfolio" is CONTRA FUSION PHARMACE's weight in each manager's 13F, not the share of Contra Fusion Pharmace the manager owns.